Germany contact info?

[NNKVa]

Hello everyone , Its the new person on the block again. I have been reading a lot of post and glad i found this site. There is a lot of great support , knowledge and helpful info given on this forum. It helps to no one is not alone in this journey. I have been looking at the different Hospital in Germany for lu-177 and it can be overwhelming to say the least. My question is ..does any one have emails , names or direct contact info they can share from there visit to Heidelberg, LMU of Munich, Saarland Homberg or the hospital you were tx at. Going thru these websites is not a easy as i thought it would be. Any info will be greatly appreciated

[HB1966]

Contact info for UK Homburg (Saarland):

Department for nuclear medicine

University Clinic Homburg

Kirrberger Straße

D-66421 Homburg

uniklinikum-saarland.de/de/...

Pof. Dr. Samer Ezzidin

[phone]

Kerstin Sutter (Coordination)

[phone]

[e-mail]

Hotel Stadt Homburg

Ringstrasse 80

D-66424 Homburg

hotel-stadt-homburg.de/

[phone]

They have special conditions for patients from the Uniklinic. From the hotel everything is within walking distance. There are also buses on the clinic premises.

Hope this helps, best wishes.

Regards Theo

[Michelle56pr in reply to HB1966]

Thanks for the info

[tango65]

Some of the centers:

Nuclear Medicine Contacts in Germany for Lu-177-PSMA Therapy

Bonn, Germany

Dr. Ahmadzadehfar is responsible for the therapy unit, which includes the Lu-177

Dr. med. Hojjat Ahmadzadehfar, M.D., Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany

Tel. [phone] 58, Fax [phone] 98 58 (office)

E-mail <[e-mail]>

Recent Publications - Rahbar K, Schmidt M, Heinzel A, Eppard E, Bode A, Yordanova A, Claesener M, Ahmadzadehfar H. Response and tolerability of a single dose of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: a multicenter retrospective analysis. J Nucl Med. 2016 Apr 7. pii: jnumed.116.173757. [Epub ahead of print]

Schlenkhoff CD, Knüpfer E, Essler M, Ahmadzadehfar H. Metastatic Prostate Cancer With Restored Hormone-Response After Radioligand Therapy With 177Lu-PSMA-617. Clin Nucl Med. 2016 Jul;41(7):572-3

Ahmadzadehfar H, Schlenkhoff CD, Rogenhofer S, Yordanova A, Essler M. 68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer. Clin Nucl Med. 2016 Sep;41(9):695-6

Fendler WP, Kratochwil C, Ahmadzadehfar H, Rahbar K, Baum RP, Schmidt M, Pfestroff A, Lützen U, Prasad V, Heinzel A, Heuschkel M, Ruf J, Bartenstein P, Krause BJ. 177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer]. Nuklearmedizin. 2016 Jun 28;55(3):123-8. German.

Bad Berka, Germany

This large center is well known for various Lu-177 clinical applications, including somatostatin and PSMA expressing cancers.

Prof. Dr. med. Richard Baum, M.D., Ph.D., Professor of Nuclear Medicine, Chairman & Clinical Director, Department of Nuclear Medicine / Center for PETCT, Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Robert-Koch-Allee 9, Bad Berka 99437, Germany

E-mail <[e-mail]> and <[e-mail]>

Tel. [phone] (office)

Private Cell – 0049-176-666-87-53 (from a few years ago – may not be current ?)

Recent Overview – R. P. Baum, et al., J. Nucl. Med., 57(8), August 2016 - Lutetium-177 PSMA Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

Heidelberg, Germany

The PSMA targeting agents were discovered at this institution, so they have extensive clinical experience with the Lu-177 agent.

Prof. Dr. med. Uwe Haberkorn, Director, Radiologische Universitätsklinik, Nuklearmedizin, Universität Heidelberg, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany

E-mail <[e-mail]>

Tel [phone] (office)

See also, klinikum.uni-heidelberg.de/...

Recent Overviews - Kratochwil C, Afshar-Oromieh A, Kopka K, Haberkorn U, Giesel FL Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer. Semin Nucl Med. 2016 Sep;46(5):405-18

Kratochwil C, Giesel FL, Stefanova M, Benešová M, Bronzel M, Afshar-Oromieh A, Mier W, Eder M, Kopka K, Haberkorn U. PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617. J Nucl Med. 2016 Aug;57(8):1170-6

Munich, Germany –

This nuclear medicine department is also very well known, and one the most respected and progressive nuclear medicine departments in Germany. The contact information for the nuclear medicine chef, Prof. Dr. Markus Schwaiger, is as follows:

Director, Department of Nuclear Medicine, Technical University of Munich, Munich, Germany

Tel. [phone] (office)

E-mail <[e-mail]>

[NNKVa in reply to tango65]

These were very helpful !Thank you so much greatly appreciated.

[tango65 in reply to NNKVa]

Best of luck!! If you need something else, send me a message using chat.

[gyancey in reply to tango65]

I was seen by Dr. Baum last December and he told me he was moving his practice close to Frankfurt.Theranosticum Franfurt-Wiesbaden

at DKD clinic

Aukammallee 33

65191 Wiesbaden, Germany

praxis-nuklearmedizin.de/en/